205 related articles for article (PubMed ID: 11067650)
1. Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery.
Coyle D; Lee KM; Fergusson DA; Laupacis A
Pharmacoeconomics; 2000 Aug; 18(2):161-71. PubMed ID: 11067650
[TBL] [Abstract][Full Text] [Related]
2. Economic analysis of erythropoietin use in orthopaedic surgery.
Coyle D; Lee KM; Fergusson DA; Laupacis A
Transfus Med; 1999 Mar; 9(1):21-30. PubMed ID: 10216902
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of epoetin and autologous blood donationin reducing allogeneic blood transfusions incoronary artery bypass graft surgery.
Marchetti M; Barosi G
Transfusion; 2000 Jun; 40(6):673-81. PubMed ID: 10864987
[TBL] [Abstract][Full Text] [Related]
4. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
6. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
7. A new protocol of iron therapy combined with epoetin alpha as a treatment for preoperative autologous blood donation in gynaecological tumor surgery.
Gargano G; Fanizza G; Polignano G; Lorusso V; De Lena M
Oncol Rep; 1999; 6(6):1349-52. PubMed ID: 10523710
[TBL] [Abstract][Full Text] [Related]
8. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
9. Autologous blood predonation in cardiac surgery.
Dietrich W
Transfus Clin Biol; 2007 Dec; 14(6):526-9. PubMed ID: 18424148
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting.
Birkmeyer JD; AuBuchon JP; Littenberg B; O'Connor GT; Nease RF; Nugent WC; Goodnough LT
Ann Thorac Surg; 1994 Jan; 57(1):161-8; discussion 168-9. PubMed ID: 8279884
[TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of preoperative autologous blood donations.
Etchason J; Petz L; Keeler E; Calhoun L; Kleinman S; Snider C; Fink A; Brook R
N Engl J Med; 1995 Mar; 332(11):719-24. PubMed ID: 7854380
[TBL] [Abstract][Full Text] [Related]
12. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.
Dupuis JY; Bart B; Bryson G; Robblee J
CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures.
Goodnough LM; Grishaber JE; Birkmeyer JD; Monk TG; Catalona WJ
Urology; 1994 Aug; 44(2):226-31. PubMed ID: 8048198
[TBL] [Abstract][Full Text] [Related]
14. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis of epoetin usage for patients with AIDS.
Cantor SB; Carson RW; Spann SJ
Pharmacoeconomics; 1993 Mar; 3(3):244-9. PubMed ID: 10146947
[TBL] [Abstract][Full Text] [Related]
16. Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
Tomeczkowski J; Stern S; Müller A; von Heymann C
PLoS One; 2013; 8(9):e72949. PubMed ID: 24039829
[TBL] [Abstract][Full Text] [Related]
17. Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.
Canan CE; Myers JA; Owens RK; Crawford CH; Djurasovic M; Burke LO; Bratcher KR; McCarthy KJ; Carreon LY
Spine (Phila Pa 1976); 2013 Apr; 38(8):703-8. PubMed ID: 23044618
[TBL] [Abstract][Full Text] [Related]
18. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes.
Vitale MG; Roye BD; Ruchelsman DE; Roye DP
Spine J; 2007; 7(3):292-300. PubMed ID: 17482112
[TBL] [Abstract][Full Text] [Related]
19. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.
Healy JC; Frankforter SA; Graves BK; Reddy RL; Beck JR
Arch Pathol Lab Med; 1994 Apr; 118(4):465-70. PubMed ID: 8166599
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Transfus Med; 1998 Dec; 8(4):309-17. PubMed ID: 9881425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
